AKAP9 anticorps (AA 1075-1125)
Aperçu rapide pour AKAP9 anticorps (AA 1075-1125) (ABIN7451618)
Antigène
Voir toutes AKAP9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1075-1125
-
Fonction
- Rabbit anti-AKAP9/CG-NAP Antibody, Affinity Purified
-
Purification
- Affinity Purified
-
Immunogène
- between AA 1075 and 1125
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IP: 2 - 5 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
-
Autre désignation
- AKAP9/CG-NAP
-
Sujet
- Background: AKAP9/CG-NAP is a member of the A-kinase anchoring protein family that functions as a molecular scaffold for the subcellular compartmentalization of A- kinase signaling molecules. AKAP9/CG-NAP has been found to be critical to repolarization in the human heart. Defects in AKAP9/CG-NAP result in long QT syndrome type 11, a heart disorder characterized by ventricular arrhythmia and prolonged QT intervals. AKAP9/CG-NAP has been shown to form a multiprotein complex with the I(Ks) potassium channel subunit and play an essential role in its phosphorylation by PKA. AKAP9/CG-NAP is also important to centrosome and microtubule cytoskeletal organization.
-
ID gène
- 10142
-
NCBI Accession
- NP_671700
-
UniProt
- Q99996
-
Pathways
- M Phase, SARS-CoV-2 Protein Interactome
Antigène
-